Sanofi Research and Development Expenses 2010-2024 | SNY

Sanofi research and development expenses for the twelve months ending September 30, 2024 were $7.754B, a 8.5% increase year-over-year.

  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
  • Sanofi annual research and development expenses for 2021 were $6.734B, a 6.63% increase from 2020.

Sanofi Research and Development Expenses 2010-2024 | SNY

  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
  • Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
  • Sanofi annual research and development expenses for 2021 were $6.734B, a 6.63% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Innoviva (INVA)$1.2B